HT-0712
N/A
Report date: 2026/02/13 20:01:31
NME
Base Information
Drug NameHT-0712
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDart Neuroscience Llc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesOrexo ABDart Neuroscience Llc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksWikipedia